Non-elective Hospitalizations in Patients Treated With Pirfenidone or Placebo over 12 Months
| All-Cause Hospitalizations | Respiratory-Related Hospitalizations | Non-Respiratory Hospitalizations | ||||
|---|---|---|---|---|---|---|
| Hospitalizations | Pirfenidone (N = 623) | Placebo (N = 624) | Pirfenidone (N = 623) | Placebo (N = 624) | Pirfenidone (N = 623) | Placebo (N = 624) |
| Events, n | 140 | 147 | 57 | 86 | 83 | 61 |
| Patients with ≥1 event | ||||||
| n (%) | 106 (17) | 112 (18) | 44 (7) | 74 (12) | 68 (11) | 51 (8) |
| Odds ratio (95% CI) | 0.94 (0.70, 1.26) | 0.56 (0.38, 0.84) | 1.38 (0.94, 2.02) | |||
| P-value | 0.662 | 0.004 | 0.099 | |||
| Died after hospitalisation, n (%) | 18 (17) | 37 (33) | 12 (27) | 34 (46) | 7 (10) | 9 (18) |